V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017141 | 160008513 | 1.54 | null | Palliative (P) | 2017-09-21 | 2017-09-22 | Chlorambucil | N | N | DOXORUBICIN + OLARATUMAB | 101822127 |
| 160017142 | 160008514 | 1.73 | 110 | Palliative (P) | 2019-08-25 | 2019-09-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100453677 |
| 160017143 | 160008515 | 1.71 | 68.7 | Palliative (P) | 2017-10-29 | 2017-11-07 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101237274 |
| 160017144 | 160008516 | 1.78 | 82 | Neo-adjuvant (N) | 2017-07-07 | 2017-07-09 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | WT SIOP 2002 01 POST OP CARBO, ETOP | 101293282 |
| 160017145 | 160008517 | 1.74 | 74.4 | Palliative (P) | 2021-09-04 | 2021-09-22 | EURO-EWING | 02 | N | LIPOSOMAL DOXORUBICIN | 100997090 |
| 160017147 | 160008518 | 1.79 | 0 | Palliative (P) | 2017-08-13 | 2017-08-27 | Trial Unspecified | 02 | N | EURO-EWING | 100685828 |
| 160017148 | 160008519 | 0 | 91.4 | Palliative (P) | 2016-03-22 | 2016-04-10 | Carboplatin AUC 6 - 10 | 2 | null | CARBOPLATIN | 101627270 |
| 160017150 | 160008520 | 1.67 | 88.6 | Palliative (P) | 2016-10-04 | 2016-10-11 | EW EuroEwing 2012 Arm B VDC | 02 | null | CYCLOPHOSPHAMIDE | 100716658 |
| 160017151 | 160008521 | null | 54.8 | Palliative (P) | 2016-06-30 | 2016-08-02 | DOXORUBICIN | N | N | DOXORUBICIN | 101212727 |
| 160017153 | 160008522 | 1.57 | 95.45 | Palliative (P) | 2017-06-17 | 2017-07-05 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101777661 |
| 160017155 | 160008523 | null | null | Curative (C) | 2017-09-06 | 2017-09-29 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101829174 |
| 160017158 | 160008524 | 1.84 | 27 | Curative (C) | 2018-03-03 | 2018-03-04 | Doxorubicin + Olaratumab | 2 | N | PACLITAXEL | 101600360 |
| 160017159 | 160008525 | 1.88 | 96.4 | Curative (C) | null | 2019-08-25 | Liposomal Doxorubicin (Caelyx) | N | N | NOT MATCHED | 101794810 |
| 160017162 | 160008526 | 1.85 | 75.7 | Disease modification (D) | 2019-04-24 | 2019-05-07 | Doxorubicin + Ifosfamide | 02 | N | NB RELAPSED CCLG GUIDELINES TVD | 100936393 |
| 160017163 | 160008527 | 0 | 20.3 | Palliative (P) | 2017-11-07 | 2017-11-14 | Cisplatin + Pemetrexed | Y | N | CISPLATIN + PEMETREXED | 101073940 |
| 160017164 | 160008528 | 0 | 29.7 | Palliative (P) | 2019-08-01 | 2019-08-05 | Cisplatin + Paclitaxel | N | null | EW EUROEWING 2012 ARM B VDC | 100139910 |
| 160017165 | 160008529 | null | null | Palliative (P) | 2018-02-12 | 2018-02-17 | PACLITAXEL | 02 | null | RITUXIMAB | 100739403 |
| 160017166 | 160008530 | 0.95 | 118 | Adjuvant (A) | 2019-03-23 | 2019-03-28 | Sunitinib | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 101531354 |
| 160017169 | 160008531 | 0 | 17.9 | Palliative (P) | 2016-08-27 | 2016-10-02 | Carboplatin AUC 2 - 5 | 2 | N | CARBOPLATIN | 100382174 |
| 160017170 | 160008532 | 1.79 | 94.1 | Curative (C) | 2017-03-07 | 2017-03-14 | Carboplatin + Paclitaxel (3 weekly) | null | N | LIPOSOMAL DOXORUBICIN | 100747430 |
| 160017172 | 160008533 | 1.78 | 112 | null | 2017-04-14 | 2017-04-18 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101312607 |
| 160017174 | 160008534 | 1.51 | 91 | null | 2018-12-25 | 2018-12-26 | Busulfan Oral | 01 | N | BEVACIZUMAB | 100074163 |
| 160017176 | 160008535 | 1.63 | 56.7 | Palliative (P) | 2019-03-20 | 2019-03-20 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100445707 |
| 160017178 | 160008536 | 1.85 | 91.4 | Curative (C) | 2018-09-14 | 2018-09-21 | Doxorubicin + Ifosfamide | 02 | N | CRIZOTINIB | 100289499 |
| 160017180 | 160008538 | 1.59 | 104.7 | Palliative (P) | 2019-10-05 | 2019-10-20 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101450540 |
| 160017182 | 160008539 | 1.72 | 75.6 | Palliative (P) | 2021-06-25 | 2021-06-28 | Ifosfamide + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + ETOPOSIDE | 100369669 |
| 160017183 | 160008540 | null | null | Curative (C) | 2018-06-08 | 2018-06-08 | Doxorubicin + Ifosfamide | 02 | null | CARBOPLATIN | 100209716 |
| 160017185 | 160008541 | 1.64 | 58 | Curative (C) | 2017-09-26 | 2017-10-10 | NB HRNBL-1 BUMEL MAT | Y | N | BORTEZOMIB + PANOBINOSTAT | 100119827 |
| 160017186 | 160008542 | 1.6 | 76.6 | Palliative (P) | 2018-11-21 | 2018-11-22 | Carboplatin + Paclitaxel (weekly) | N | N | CARBOPLATIN + PACLITAXEL | 101204364 |
| 160017187 | 160008543 | 1.73 | 82 | Curative (C) | 2019-05-21 | 2019-05-21 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CISPLATIN + VINORELBINE | 100982620 |
| 160017189 | 160008544 | 1.74 | 103 | null | 2016-10-28 | 2016-11-20 | Liposomal Doxorubicin (20mg/m2) | 02 | Y | EW EUROEWING 2012 ARM B VDC | 100706962 |
| 160017190 | 160008545 | 1.74 | 75.7 | Palliative (P) | 2019-03-31 | 2019-03-31 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101300246 |
| 160017194 | 160008546 | 1.81 | 72.4 | Palliative (P) | 2018-06-23 | 2018-07-06 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 101188298 |
| 160017196 | 160008547 | 1.65 | 66 | Curative (C) | 2018-01-19 | 2018-01-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100729238 |
| 160017199 | 160008548 | 1.82 | 66 | Palliative (P) | 2018-06-02 | 2018-06-14 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100719924 |
| 160017200 | 160008549 | 1.78 | 80.6 | null | 2019-06-01 | 2019-06-20 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101515987 |
| 160017205 | 160008550 | 1.71 | 72.5 | Adjuvant (A) | 2016-10-27 | 2016-11-10 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100347969 |
| 160017207 | 160008551 | 1.6 | 57 | null | 2017-07-27 | 2017-08-15 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101150301 |
| 160017208 | 160008552 | 1.79 | 79 | Palliative (P) | 2017-07-09 | 2017-07-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100949959 |
| 160017212 | 160008553 | 1.75 | 86.5 | Curative (C) | 2016-02-12 | 2016-02-16 | NB HRNBL-1 COJEC Ind COURSE A | N | N | DABRAFENIB + TRAMETINIB | 101707123 |
| 160017214 | 160008554 | 1.75 | 85.8 | Palliative (P) | 2020-12-03 | 2020-12-03 | Doxorubicin + Olaratumab | 01 | N | DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 101709505 |
| 160017215 | 160008555 | 0 | 18.2 | Palliative (P) | 2018-05-15 | 2018-05-22 | Doxorubicin + Ifosfamide | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100400843 |
| 160017216 | 160008556 | 1.54 | 83.9 | Disease modification (D) | 2017-06-29 | 2017-07-01 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101196585 |
| 160017217 | 160008557 | 1.55 | 77.9 | Palliative (P) | null | null | MELPHALAN | 02 | null | OXALIPLATIN + MDG | 100378296 |
| 160017219 | 160008558 | 1.62 | 98.4 | Palliative (P) | 2016-08-26 | 2016-09-03 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101529211 |
| 160017220 | 160008559 | 0 | 65.45 | null | 2016-09-28 | 2016-10-05 | EW EuroEwing 2012 Arm A VIDE | null | N | CISPLATIN + ETOPOSIDE | 101402976 |
| 160017222 | 160008560 | 1.71 | 63.9 | Palliative (P) | 2018-01-29 | 2018-02-01 | Liposomal Doxorubicin (Caelyx) | 02 | N | TRIAL UNSPECIFIED | 100311295 |
| 160017225 | 160008561 | 1.68 | 66 | Adjuvant (A) | 2018-11-13 | 2018-11-13 | ETOP 13-18 BEAT-meso Trial | 02 | N | BEP | 101373421 |
| 160017226 | 160008562 | 1.71 | 78 | 03 | 2015-09-23 | 2015-09-23 | Docetaxel+Gemcitabine (no prior RT) | N | N | LIPOSOMAL DOXORUBICIN | 100643478 |
| 160017227 | 160008563 | 1.8 | 101 | Palliative (P) | 2018-05-04 | 2018-05-13 | Liposomal Doxorubicin (Caelyx) | 02 | N | TRIAL UNSPECIFIED | 100296549 |